143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
The link between headache disorders and suicide—a 25-year Danish cohort study

The link between headache disorders and suicide—a 25-year Danish cohort study

by Justin Jackson , Medical XpressCredit: Kindel Media from PexelsNew evidence from a large population-based cohort analysis indicates an increased risk of both attempted and completed suicide among i

The link between headache disorders and suicide—a 25-year Danish cohort study

by Justin Jackson , Medical XpressCredit: Kindel Media from PexelsNew evidence from a large population-based cohort analysis indicates an increased risk of both attempted and completed suicide among i
Increased chances for early detection of Alzheimer's disease

Increased chances for early detection of Alzheimer's disease

by Lund UniversityA method for detecting early signs of Alzheimer's disease using amyloid PET imaging works as well as the previously used cerebrospinal fluid sample method. This is the concl

Increased chances for early detection of Alzheimer's disease

by Lund UniversityA method for detecting early signs of Alzheimer's disease using amyloid PET imaging works as well as the previously used cerebrospinal fluid sample method. This is the concl
Researchers discover possible new cause for Alzheimer's disease

Researchers discover possible new cause for Alzheimer's disease

by Arielle Robinson, The Atlanta Journal-ConstitutionCredit: Pixabay/Pete Linforth.Scientists at Oregon Health and Science University have made a development that could lead to a greater understanding

Researchers discover possible new cause for Alzheimer's disease

by Arielle Robinson, The Atlanta Journal-ConstitutionCredit: Pixabay/Pete Linforth.Scientists at Oregon Health and Science University have made a development that could lead to a greater understanding
FDA head calls for inquiry into Alzheimer's drug review

FDA head calls for inquiry into Alzheimer's drug review

by Matthew PerroneThis image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Friday, July 9, 2021, the acting head of the U.S. Food and Drug Administrati

FDA head calls for inquiry into Alzheimer's drug review

by Matthew PerroneThis image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Friday, July 9, 2021, the acting head of the U.S. Food and Drug Administrati
Can having a stroke change your sleep?

Can having a stroke change your sleep?

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainPeople who have had a stroke may be more likely to sleep too much or too little compared to those without prior stroke, according

Can having a stroke change your sleep?

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainPeople who have had a stroke may be more likely to sleep too much or too little compared to those without prior stroke, according
Discovery of molecular mechanism involved in early brain development provides insights into microcephaly pathogenesis

Discovery of molecular mechanism involved in early brain development provides insights into microcephaly pathogenesis

byTohoku UniversityAn overview of Kif23's involvement in embryonic brain development, highlighting how its deficiency disrupts cell division and potentially contribute to microcephaly. Credi

Discovery of molecular mechanism involved in early brain development provides insights into microcephaly pathogenesis

byTohoku UniversityAn overview of Kif23's involvement in embryonic brain development, highlighting how its deficiency disrupts cell division and potentially contribute to microcephaly. Credi
Scientists discover a variation of the genome predisposing to Alzheimer's disease

Scientists discover a variation of the genome predisposing to Alzheimer's disease

by IDIBELL-Bellvitge Biomedical Research InstituteExample of cells of a patient with advanced Alzheimer's with an altered PM20D1 gene. Credit: IDIBELLAn article published inNature Medic

Scientists discover a variation of the genome predisposing to Alzheimer's disease

by IDIBELL-Bellvitge Biomedical Research InstituteExample of cells of a patient with advanced Alzheimer's with an altered PM20D1 gene. Credit: IDIBELLAn article published inNature Medic
Signs of Alzheimer's disease may be detectable before significant symptoms are obvious

Signs of Alzheimer's disease may be detectable before significant symptoms are obvious

by University of GlasgowCredit: Pixabay/CC0 Public DomainHealthy people with a higher genetic risk of Alzheimer's disease may show differences in brain structure and in cognitive test scores

Signs of Alzheimer's disease may be detectable before significant symptoms are obvious

by University of GlasgowCredit: Pixabay/CC0 Public DomainHealthy people with a higher genetic risk of Alzheimer's disease may show differences in brain structure and in cognitive test scores
Image: Neurologist creates image of Alzheimer's plaque in neurons

Image: Neurologist creates image of Alzheimer's plaque in neurons

by Bill Hathaway,Yale UniversityThe effects of the plaques on the brains of Alzheimer's patients are devastating.But when postdoctoral associate Peng Yuan and Dr. Jaime Grutzendler, associat

Image: Neurologist creates image of Alzheimer's plaque in neurons

by Bill Hathaway,Yale UniversityThe effects of the plaques on the brains of Alzheimer's patients are devastating.But when postdoctoral associate Peng Yuan and Dr. Jaime Grutzendler, associat
Sensory interventions can benefit patients with dementia

Sensory interventions can benefit patients with dementia

(HealthDay)—For patients with dementia, there are many available sensory interventions that seem to have significant effects, according to a review published online March 31 in theJournal of Cli

Sensory interventions can benefit patients with dementia

(HealthDay)—For patients with dementia, there are many available sensory interventions that seem to have significant effects, according to a review published online March 31 in theJournal of Cli
Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe